In a patient admitted with complicated urinary tract infection, fever, and poorly controlled diabetes, who is receiving ceftriaxone and had a normal chest X‑ray on admission, now develops a cough on day 3–4 without fever or shortness of breath, should the antibiotic regimen be changed or an additional antibiotic added?

Do Not Change or Add Antibiotics

In this patient with isolated cough on day 3-4 without fever, shortness of breath, or abnormal vital signs, you should continue ceftriaxone alone without changing or adding antibiotics. The cough most likely represents acute bronchitis or a self-limited viral process, not pneumonia requiring additional coverage.

Clinical Reasoning

Why This Cough Does Not Warrant Antibiotic Changes

The key clinical features argue strongly against pneumonia:

• No fever recurrence - The absence of fever makes bacterial pneumonia unlikely
• No dyspnea - Shortness of breath is a cardinal feature of pneumonia that is absent here
• Normal admission chest X-ray - Provides baseline reassurance
• Isolated cough alone - This is the only new symptom

According to CHEST guidelines, antibiotics should NOT be routinely used for acute cough when vital signs and lung exams are normal and there is no clinical or radiographic evidence of pneumonia 1. The guidelines specifically state that cough with dyspnea, fever ≥38°C, tachypnea, and new localizing chest examination signs are what suggest pneumonia 1.

What You Should Do Instead

Perform a focused clinical assessment:

1. Check vital signs - Look specifically for:

   • Temperature ≥38°C
   • Tachypnea (respiratory rate >20)
   • Tachycardia
   • Oxygen saturation

2. Examine the chest - Listen for:

   • New crackles
   • Diminished breath sounds
   • Signs of consolidation
   • Any localizing findings

3. If vital signs are abnormal OR new focal chest findings are present - Order a chest X-ray to evaluate for pneumonia 1

4. If CRP is available - A level <10 mg/L or 10-50 mg/L without dyspnea and daily fever makes pneumonia unlikely 1

Continue Current Therapy

Ceftriaxone remains appropriate for the complicated UTI 2. The drug label confirms its indication for complicated urinary tract infections, and recent research shows it is effective for UTIs in diabetic patients despite concerns about resistance 3, 4.

Important Caveats

Watch for These Red Flags

If any of the following develop, reassess immediately:

• Fever returns - Suggests new infection or treatment failure
• Dyspnea develops - Key indicator of lower respiratory tract involvement
• Vital sign abnormalities - Tachypnea, tachycardia, hypoxia
• New focal chest findings - Crackles, consolidation on exam

Common Pitfall to Avoid

Do not reflexively add respiratory coverage (like azithromycin or a fluoroquinolone) for isolated cough in a hospitalized patient. This leads to unnecessary antibiotic exposure, increased resistance, and potential adverse effects including Clostridioides difficile infection. The CHEST guidelines explicitly recommend against routine antibiotics for acute cough without clinical or radiographic pneumonia evidence 1.

Special Consideration in Diabetes

While diabetic patients have increased UTI susceptibility and complications 4, 5, 6, this does not change the threshold for diagnosing or treating pneumonia. The same clinical criteria apply. However, ensure glucose control is optimized, as hyperglycemia can impair immune function and prolong recovery 6.

Duration of Current Therapy

Once the UTI is adequately treated (typically 5-7 days for complicated UTI in the context of diabetes and fever), you can discontinue ceftriaxone. The isolated cough will likely resolve spontaneously as it represents acute bronchitis, which is typically viral and self-limited 7.